- Home
- CTXR vs FTFT Comparison
CTXR vs FTFT Comparison
Compare CTXR & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- FTFT
- Stock Information
- Founded
- CTXR 2007
- FTFT N/A
- Country
- CTXR United States
- FTFT United States
- Employees
- CTXR N/A
- FTFT N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- CTXR Health Care
- FTFT Consumer Discretionary
- Exchange
- CTXR Nasdaq
- FTFT Nasdaq
- Market Cap
- CTXR 21.6M
- FTFT 19.7M
- IPO Year
- CTXR N/A
- FTFT N/A
- Fundamental
- Price
- CTXR $1.67
- FTFT $2.50
- Analyst Decision
- CTXR Strong Buy
- FTFT
- Analyst Count
- CTXR 3
- FTFT 0
- Target Price
- CTXR $53.00
- FTFT N/A
- AVG Volume (30 Days)
- CTXR 1.5M
- FTFT 5.2M
- Earning Date
- CTXR 08-11-2025
- FTFT 08-18-2025
- Dividend Yield
- CTXR N/A
- FTFT N/A
- EPS Growth
- CTXR N/A
- FTFT N/A
- EPS
- CTXR N/A
- FTFT N/A
- Revenue
- CTXR N/A
- FTFT $2,031,913.00
- Revenue This Year
- CTXR N/A
- FTFT N/A
- Revenue Next Year
- CTXR N/A
- FTFT N/A
- P/E Ratio
- CTXR N/A
- FTFT N/A
- Revenue Growth
- CTXR N/A
- FTFT N/A
- 52 Week Low
- CTXR $0.65
- FTFT $1.01
- 52 Week High
- CTXR $26.25
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- CTXR 56.18
- FTFT 57.54
- Support Level
- CTXR $1.40
- FTFT $2.35
- Resistance Level
- CTXR $1.67
- FTFT $2.98
- Average True Range (ATR)
- CTXR 0.18
- FTFT 0.49
- MACD
- CTXR -0.03
- FTFT 0.03
- Stochastic Oscillator
- CTXR 36.90
- FTFT 44.36
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.